{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:48:44Z","timestamp":1761821324786,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jneuroim.2013.01.006","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T02:47:38Z","timestamp":1360637258000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Macrophage migration inhibitory factor is necessary for the Lipo-oligosaccharide-induced response by modulation of Toll-like receptor 4 in monocytes from GBS patients"],"prefix":"10.1016","volume":"257","author":[{"given":"Yu-Zhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa-Fa","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.01.006_bb0005","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1212\/01.wnl.0000310983.38724.d4","article-title":"Guillain\u2013Barre syndrome: incidence and mortality rates in US hospitals","volume":"70","author":"Alshekhlee","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell\u2013antigen interaction","volume":"56","author":"David","year":"1966","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0015","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1432-2277.2005.00197.x","article-title":"Blockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft","volume":"18","author":"Fukuyama","year":"2005","journal-title":"Transpl. Int."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/08916930903229239","article-title":"Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB\/W mice","volume":"43","author":"Graham","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0025","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.4049\/jimmunol.1002971","article-title":"IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3","volume":"186","author":"Greenhill","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0175","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain\u2013Barre syndrome","author":"Hughes","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0035","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/jcbfm.2010.194","article-title":"Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke","volume":"31","author":"Inacio","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1465-9921-9-30","article-title":"Differential regulation of CCL-11\/eotaxin-1 and CXCL-8\/IL-8 by gram-positive and gram-negative bacteria in human airway smooth muscle cells","volume":"9","author":"Issa","year":"2008","journal-title":"Respir. Res."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2006.11.007","article-title":"Expression and function of Toll-like receptors in T lymphocytes","volume":"19","author":"Kabelitz","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0050","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0952-7915(03)00080-3","article-title":"Recognition of microbial infection by Toll-like receptors","volume":"15","author":"Kopp","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cellimm.2007.04.003","article-title":"TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae","volume":"245","author":"Lee","year":"2007","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0060","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.RES.87.12.1202","article-title":"De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits","volume":"87","author":"Lin","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0065","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00415-010-5836-5","article-title":"The role of cytokines in Guillain\u2013Barre syndrome","volume":"258","author":"Lu","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0075","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1286-4579(02)01560-5","article-title":"Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease","volume":"4","author":"Lue","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0080","doi-asserted-by":"crossref","first-page":"18100","DOI":"10.1074\/jbc.274.25.18100","article-title":"Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action","volume":"274","author":"Mitchell","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0085","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.transproceed.2011.02.054","article-title":"Transforming growth factor-beta1 modulates lipopolysaccharide-induced cytokine\/chemokine production and inhibits nuclear factor-kappaB, extracellular signal-regulated kinases and p38 activation in dendritic cells in mice","volume":"43","author":"Mou","year":"2011","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1756-0500-2-171","article-title":"The epidemiology of Guillain\u2013Barre Syndrome in U.S. military personnel: a case\u2013control study","volume":"2","author":"Nelson","year":"2009","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneuroim.2005.07.019","article-title":"Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain\u2013Barre syndrome and experimental allergic neuritis","volume":"168","author":"Nicoletti","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0100","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.4049\/jimmunol.175.9.5611","article-title":"Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis","volume":"175","author":"Powell","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024532715775","article-title":"Aberrated levels of cerebrospinal fluid chemokines in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"23","author":"Press","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1172\/JCI26078","article-title":"Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis","volume":"116","author":"Prinz","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/09680519030090020801","article-title":"Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4)","volume":"9","author":"Roger","year":"2003","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0120","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1172\/JCI1524","article-title":"Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma","volume":"101","author":"Rossi","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/eji.200838617","article-title":"Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients","volume":"39","author":"Rudnicka","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","article-title":"The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain\u2013Barre syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Sainaghi","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0135","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.4049\/jimmunol.1100967","article-title":"Hck tyrosine kinase regulates TLR4-induced TNF and IL-6 production via AP-1","volume":"187","author":"Smolinska","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0008-8749(02)00516-6","article-title":"In vitro and in vivo regulation by macrophage migration inhibitory factor (MIF) of expression of MHC-II, costimulatory, adhesion, receptor, and cytokine molecules","volume":"217","author":"Stavitsky","year":"2002","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0150","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barre syndrome. Dutch Guillain\u2013Barre Study Group","volume":"326","author":"van der Meche","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2013.01.006_bb0155","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1007\/s10875-010-9407-4","article-title":"IVIG treatment and prognosis in Guillain\u2013Barre syndrome","volume":"30","author":"van Doorn","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000328200","article-title":"Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain\u2013Barre syndrome","volume":"19","author":"Wang","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0165","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain\u2013Barre syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2013.01.006_bb0170","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1212\/WNL.0b013e3181e7920c","article-title":"Axonal variant of Guillain\u2013Barre syndrome associated with campylobacter infection in Bangladesh","volume":"75","author":"Zhang","year":"2010","journal-title":"Neurology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:20:12Z","timestamp":1759047612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":34,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0165572813000209"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.01.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage migration inhibitory factor is necessary for the Lipo-oligosaccharide-induced response by modulation of Toll-like receptor 4 in monocytes from GBS patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}